Press release
Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027
The Psoriatic Arthritis market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers. This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.Know more: https://www.arizton.com/market-reports/psoriatic-arthritis-treatment-market
Increasing Adoption of Biological Therapies
Biological therapies such as anti-tumor necrosis factor (TNF) and anti-interleukin antibodies are widely used in the psoriatic arthritis treatment market. With Stelara being biologic approved for PsA in 2013, there is a demand for therapies with novel MOAs that are less immunogenic than current offerings. Many new classes of therapies are looking to enter the psoriatic arthritis treatment market over the next few years. The biologics such as interleukin inhibitors are making inroads into the psoriatic arthritis market owing to better clinical profile and convenient patient dosing.
Looking for free sample report: https://www.arizton.com/request-sample/3517
Key Vendors
AbbVie Inc.
Business Overview
Product Offerings
Johnson & Johnson
UCB SA
Amgen
Bristol-Myers Squibb
Pfizer
Eli Lilly and Company
Novartis
Other Prominent Vendors
Samsung Bioepis
Boehringer Ingelheim
Mylan
Merck & Co., Inc
Coherus BioSciences, Inc
Key Emerging Vendors with Late Stage Pipeline Drugs
Sun Pharmaceuticals
Bausch Health Companies Inc
Jiangsu HengRui Medicine Co. Ltd
Biocad Biopharmaceutical
Meiji Holdings Co Ltd
Bio-Thera
Segmentation by Drug Class
TNF Inhibitors
Interleukin Inhibitors
NSAIDs
Other classes of Drugs
Segmentation by Disease Type
Spondylitis
Enthesitis
Dactylitis
Segmentation by Gender Type
Men
Women
Segmentation by Age Group
50 years and Below
50 years and Above
Segmentation by Severity Type
Moderate
Mild
Severe
Segmentation by Geography
North America
United States
APAC
China
Japan
Europe
U.K.
France
German
Italy
Spain
Table of Content
PSORIATIC ARTHRITIS OVERVIEW
Psoriatic Arthritis Disease - An Overview
PSORIATIC ARTHRITIS EPIDEMIOLOGY & OVERVIEW
8MM: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
8MM: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
8MM: Historic & Projected Volume of incidence of Psoriatic Arthritis cases by Disease Type
8MM: Historic & Projected Volume of incidence of Psoriatic Arthritis cases by Severity Type
8MM: Historic & Projected Volume of Incidence of Psoriatic Arthritis cases by Gender & Age Group
8MM: Historic & Projected Volume of Prevalence of Psoriatic Arthritis cases by Disease type
8MM: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
8MM: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
US: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
US: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
US: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
US: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
US: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
US: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
US: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
US: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
China: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
China: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
China: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
China: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
China: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
China: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
China: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
China: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
Japan: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
Japan: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
Japan: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
Japan: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
Japan: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
Japan: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
Japan: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
Japan: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
Germany: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
Germany: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
Germany: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
Germany: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
Germany: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
Germany: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
Germany: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
Germany: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
UK: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
UK: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
UK: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
UK: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
UK: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
UK: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
UK: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
UK: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
France: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
France: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
France: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
France: Historic & Projected Volume of incidence of Psoriatic Arthritis cases by Severity Type
France: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
France: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
France: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
France: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
Italy: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
Italy: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
Italy: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
Italy: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
Italy: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
Italy: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
Italy: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
Italy: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
Spain: Historic & Projected Volume of Incidence & Prevalence of Psoriatic Arthritis
Spain: Comparative Analysis of Incidence & Prevalence of Psoriatic Arthritis
Spain: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Disease Type
Spain: Historic & Projected Volume of incidence of Psoriatic Arthritis Cases by Severity Type
Spain: Historic & Projected Volume of Incidence of Psoriatic Arthritis Cases by Gender & Age Group
Spain: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Disease Type
Spain: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Severity Type
Spain: Historic & Projected Volume of Prevalence of Psoriatic Arthritis Cases by Gender & Age Group
PSORIATIC ARTHRITIS MARKET SIZE & OVERVIEW
8MM: Historic & Projected Revenue of Psoriatic Arthritis
8MM: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
8MM: Major Approved Drugs in Psoriatic Arthritis
8MM: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
US: Historic & Projected Revenue of Psoriatic Arthritis
US: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
US: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
China: Historic & Projected Revenue of Psoriatic Arthritis
China: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
China: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
Japan: Historic & Projected Revenue of Psoriatic Arthritis
Japan: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
Japan: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
Germany: Historic & Projected Revenue of Psoriatic Arthritis
Germany: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
Germany: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
UK: Historic & Projected Revenue of Psoriatic Arthritis
UK: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
UK: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
France: Historic & Projected Revenue of Psoriatic Arthritis
France: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
France: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
Italy: Historic & Projected Revenue of Psoriatic Arthritis
Italy: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
Italy: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
Spain: Historic & Projected Revenue of Psoriatic Arthritis
Spain: Historic & Projected Revenue of Psoriatic Arthritis Snapshot
Spain: Historic & Projected Revenue Segmentation by Gender Type, Disease Type, Severity, Age Group & Drug Class
PSORIATIC ARTHRITIS MARKETED DRUGS OVERVIEW
Psoriatic Arthritis Marketed Drugs - An Overview
Psoriatic Arthritis Marketed Drugs - Summary
PSORIATIC ARTHRITIS PIPELINE DRUGS OVERVIEW
Psoriatic Arthritis Pipeline Drugs - An Overview
Psoriatic Arthritis Pipeline Drugs - Snapshot
Psoriatic Arthritis Pipeline Drugs Overview & Snapshot - By Disease type
Psoriatic Arthritis Pipeline Drugs Overview & Snapshot - By Development Phase
Psoriatic Arthritis Pipeline Drugs Overview & Snapshot - By Route of Administration
Psoriatic Arthritis Pipeline Drugs Overview & Snapshot - By Mechanism of Action
Psoriatic Arthritis Pipeline Drugs Overview & Snapshot - By Molecule type
Psoriatic Arthritis Pipeline Drugs Overview & Snapshot - By Geography type
PSORIATIC ARTHRITIS CLINICAL TRIALS OVERVIEW
Psoriatic Arthritis Clinical Trials Overview Snapshot
Psoriatic Arthritis Clinical Trials Overview - By Recruitment Status
Psoriatic Arthritis Clinical Trials Overview - By Product type
Psoriatic Arthritis Clinical Trials Overview - By Route of Administration
Psoriatic Arthritis Clinical Trials Overview - By Molecule type
Psoriatic Arthritis Clinical Trials Overview - By Geography type
PSORIATIC ARTHRITIS MARKET DYNAMICS
Psoriatic Arthritis Therapeutics Market Drivers
Psoriatic Arthritis Therapeutics Market Constraints
Psoriatic Arthritis Therapeutics Market Trends
PSORIATIC ARTHRITIS COMPETITIVE LANDSCAPE
Psoriatic Arthritis Competitive Landscape - Marketed Drugs
Key Company Profiles
Other Key Company Profiles
Competitive Scenario of Psoriatic Arthritis therapeutics market
Key Company Profile Snapshot
Other Key Company Profile Snapshot
Psoriatic Arthritis Competitive Landscape - Pipeline Drugs
Key Emerging Company Profiles
Other Key Emerging Company Profiles
Key Company Profile Snapshot
PSORIATIC ARTHRITIS MISCELLANEOUS
Key Tentative Drug Approvals Timeline
Key Regulatory Designations
Key Milestones
Deals & Collaborations
Inactive/Discontinued/Dormant Products
APPENDIX
About Arizton
Research Methodology
List of Abbreviations
ABOUT ARIZTON:
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals, and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Call: +1-312-235-2040
+1 302 469 0707
Mail: enquiry@arizton.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriatic Arthritis Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 here
News-ID: 2781139 • Views: …
More Releases for Psoriatic
Psoriatic Arthritis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Psoriatic Arthritis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Psoriatic Arthritis Research. Learn more about…
Psoriatic Arthritis Treatment: A New Era of Relief
The Business Research Company recently released a comprehensive report on the Global Psoriatic Arthritis Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The psoriatic arthritis treatment…
Psoriatic Arthritis Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Psoriatic Arthritis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Psoriatic Arthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Psoriatic Arthritis Pipeline Report
• Over 20+…
Psoriatic Arthritis Treatment Market - Unleash the Power of Relief: Elevating Tr …
Newark, New Castle, USA - Growth Plus Reports has published a new report on Psoriatic Arthritis Treatment Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Psoriatic Arthritis Treatment provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes…
Psoriatic Arthritis Treatment Market Size, CAGR | Growth - 2030
Exclusive Report by Ameco Research: Psoriatic Arthritis Treatment Market Size Projected to Reach USD 26 Billion by 2030, Growing at 9.60% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Psoriatic Arthritis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality…
Psoriatic Arthritis Treatment Market Growth Framework 2025
Global Psoriatic Arthritis Treatment Market: Overview
The demand within the global psoriatic arthritis treatment market has been rising on account of advancements in the field of healthcare and biosimilar analysis. The occurrence of psoriatic arthritis can place an extremely negative toll on the overall health of individuals. This is because psoriatic arthritis is more severe than any other form of arthritis. Under psoriatic arthritis, patients suffering from a skin condition called…
